Skip to main content

Advertisement

Table 1 Characteristics of participants with HIV viral loads ≥1000 copies/ml at enrolment by ART regimen line

From: From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults

Characteristic All participants n (%) ART regimen line
First line ART n (%) Second line ART n (%)
All (n, row %) 110 74 (67.3) 36 (32.7)
Study site
Entebbe 90 (81.8) 65 (87.8) 25 (69.4)
Kyamulibwa 20 (18.2) 9 (12.2) 11 (30.6)
Sex
Females 73 (66.4) 53 (71.6) 20 (55.6)
Males 37 (33.6) 21 (28.4) 16 (44.4)
Age, years
18–34 15 (13.6) 6 (8.1) 9 (25.0)
35–49 72 (65.5) 50 (67.6) 22 (61.1)
50+ 23 (20.9) 18 (24.3) 5 (13.9)
Body Mass Index (kg/m 2 ) a
<18.5 15 (13.6) 7 (9.5) 8 (22.2)
18.5–24.9 63 (57.3) 44 (59.5) 19 (52.8)
25.0–29.9 20 (18.2) 14 (18.9) 6 (16.7)
≥30 11 (10.0) 8 (10.8) 3 (8.3)
HIV subtype
A 37 (33.6) 25 (33.8) 12 (33.3)
B 5 (4.5) 3 (4.1) 2 (5.6)
C 6 (5.5) 5 (6.8) 1 (2.8)
D 38 (34.5) 22 (29.7) 16 (44.4)
CRF01_AE 24 (21.8) 19 (25.7) 5 (13.9)
CD4 cell counts at enrolmentcells/ml b
≤350 65 (59.1) 41 (55.4) 24 (66.7)
351–500 26 (23.6) 22 (29.7) 4 (11.1)
501+ 11 (10.0) 5 (6.8) 6 (16.7)
Total duration on ART, years
0–<5 15 (13.6) 9 (12.2) 6 (16.7)
5–<9 6 (5.5) 2 (2.7) 4 (11.1)
9+ 89 (80.9) 63 (85.1) 26 (72.2)
Duration on current ART regimen, years c
<5 17 (15.5) 9 (12.2) 8 (22.2)
5–<9 17 (15.5) 2 (2.7) 15 (41.7)
9+ 63 (57.3) 63 (85.1) 0 (0.0)
Viral loads (copies/ml)
1000–9999 43 (39.1) 29 (39.2) 14 (38.9)
10,000+ 67 (60.9) 45 (60.8) 22 (61.1)
  1. Missing variable data: a = 1 patient on first line ART, b = 8 patients (6 on first and 2 on second line ART), c = 13 patients on second line ART